OFFICE OF FISCAL ANALYSIS
Legislative Office Building, Room 5200
Hartford, CT 06106 (860) 240-0200
http://www.cga.ct.gov/ofa
SB-1324
AN ACT AUTHORIZING EMERGENCY MEDICAL SERVICES
PERSONNEL TO ADMINISTER GLUCAGON NASAL POWDER.
Primary Analyst: RP 3/11/25
Contributing Analyst(s): NB, DD
Reviewer: PR
OFA Fiscal Note
State Impact:
Agency Affected Fund-Effect FY 26 $ FY 27 $
UConn; UConn Health Ctr. GF - Potential
Cost
See Below See Below
Note: GF=General Fund
Municipal Impact:
Municipalities Effect FY 26 $ FY 27 $
Various Municipalities Potential
Cost
See Below See Below
Explanation
The bill results in a potential cost to (1) the University of Connecticut,
(2) UConn Health, and (3) various municipalities, by allowing
emergency medical services (EMS) personnel to acquire and administer
glucagon nasal powder should its use be deemed necessary. Glucagon
nasal powder has an approximate per unit cost of $300.
The bill results in an additional potential cost, by requiring all EMS
personnel
1
to receive training in the administration of glucagon nasal
powder. The potential cost depends on the extent that the current EMS
training curriculums can incorporate such training without increasing
1
Under the bill, “EMS personnel” are (1) certified emergency medical responders, (2)
any class of certified emergency medical technicians (EMTs), including advanced
EMTs, and (3) licensed paramedics. 2025SB-01324-R000079-FN.DOCX Page 2 of 2
training hours and costs.
The Out Years
The annualized ongoing fiscal impact identified above would
continue into the future subject to the usage rate of glucagon nasal
powder and inflation.